Albert N Ngo

Open door policy or email appointment

ADV Pharmaceutics III & PHA 6180 PHA 4107 Drug Delivery III  M, W, F - 9:00 a.m – 9:50 a.m.
ADV Pharmaceutics I & PHA 3102 Drug Delivery I T, Th - 1:00 p.m-1:50 p.m. and Fr. 12:00 p.m-12:50 p.m
Pharmaceutics I (PHA 3110) M, W, F - 1:00 p.m.-1:50 p.m
Pharmaceutical Sciences Concepts I M&W 11:15 a.m-1:00 p.m.

---

---

Dr. Ngo received his B.S. degree in chemical engineering from the National Polytechnic Institute Felix Houphouët-Boigny-Yamoussoukro, Cote d’Ivoire in 2008 and his Ph.D. degree in pharmaceutics and drug design from the University of Missouri-Kansas City, Missouri, United States, in 2018. Dr. Ngo published his research work in prestigious ac-ademic platforms such as Pharmaceutical Research, IJP, etc. He is the inventor of two United States patents. In July 2023, Dr. Ngo joined FAMU-COPPS,IPH, as an Assistant Professor of Pharmaceutics. His research interest is developing “smart” nanoparticles (SSFNs), targeting PSMA for prostate cancer therapy.

---

---

• Drug Discovery and Translational Research
  
• Nanotheranostics
  
• Nanoparticle Drug delivery system
  
• Pharmacogenomic
  
• Material Science
  

---

---

---

---

• Post-Doctoral Associate- 7/2018-12/2018.
  University of Missouri-Kansas City, Kansas City, MO
• Assistant Professor of Pharmaceutical Science (Full time). 2019-2023
  American University of Health Sciences, Signal Hill, CA
• Clinical Assistant Professor (Part-time), 2019-2023
  Charles R. Drew University of Medicine and Science, Los Angeles, CA
• Assistant Professor of Pharmaceutical Science 2023-Present
  Florida A&M University, Tallahassee, FL

---

---

•  Ngo AN; Yang S; Wu Y; Schloss J, Vadgama J. Engineering of Layer-By-Layer Smart Acetate Coated Paclitaxel Loaded Polylactic-Co-Glycolic Acid Nanoparticles to Treat Prostate Cancer RCMI and ACS diversity in Cancer research Abstract, 2023
  
  
• Ngo AN, Murowchick J; Gounevc AD, Gounev TK; Youan C.B a, *, "Physico-Chemistry and Cytotoxicity of Tenofovir Loaded Acid Phosphatase Responsive Chitosan Nanoparticles," AAPS Pharmscitech ( 2023)
  
•  Inventors: Ngo NA, Bi-Botti C. Youan Formulations For Pharmaceutical Agents
  U.S. Patent App. No. 16/847,960, Issued date, 12/20/2022
  https://patentcenter.uspto.gov/applications/16847960
  
  
• go, A.N., Islam, M.A., Aoyagi, J. et al. Prevalence of Hypertension in Homeless Adults: An Interprofessional Education Community-Based Health Fairs Cross-Sectional Study in Urban Long Beach, California. High Blood Press Cardiovasc Prev 28, 63–68 (2021). https://doi.org/10.1007/s40292-020-00424-8
  
•  Inventors; Ngo NA, Bi-Botti C. Youan; Preparation of acetate Salt composition of Pharmaceutical Agents US Patent#15/178938, Issued date, 02/26/2019
  https://patentcenter.uspto.gov/applications/15178938
  
  
• Ngo AN, David Turbow; Principal Component Analysis of Morbidity and Mortality among the United States Homeless Population: A Systematic Review and Meta-Analysis., Int Arch Public Health Community Med 2019, 3:025.
  
  
• Ngo AN, Engineering of Human Acid Phosphatase Enzyme Sensitive Nanomedicine for HIV/AIDS Prevention by Topical Route, University of Missouri Kansas City, 2018. https://mospace.umsystem.edu/xmlui/handle/10355/68861
  
  
• Ngo AN.; Thomas, D.; Murowchick, J.; Ayon, N. J.; Jaiswal, A.; Youan, B. C., Engineering fast dissolving sodium acetate mediated crystalline solid dispersion of docetaxel. Int J Pharm 2018, 545 (1-2), 329-341.
  
  
• Ngo AN, Ezoulin MJ, Murowchick JB, Gounev AD, & Youan BB (2016) Sodium Acetate Coated Tenofovir-Loaded Chitosan Nanoparticles for Improved Physico-Chemical Properties. Pharm Res 33(2):367-383
  
  
•  Ngo AN, Ezoulin MJ, Youm I, & Youan BB (2014) Optimal Concentration of 2,2,2-Trichloroacetic Acid for Protein Precipitation Based on Response Surface Methodology. J Anal Bioanal Tech 5(4).
  

---

---

• FAMU Albert Nguessan Ngo (PI) 10/2023-06/2024 125,000 USD
  PI start-up
  
  
• CDU DCRT/ACS Albert Nguessan Ngo (PI) 5/2022-5/2023 30,000 USD
  
  
• CDU Division of Cancer Research and Training (DCRT) and American Cancer Society (ACS) Award for a project titled Development of 'Smart' Acetate-Coated Nanoparticles to Treat Prostate Cancer.

---

---

•  PPHA 4107 Drug Delivery III
  
• PHA6180_301_2238 Adv Pharmaceutics I
  
• PHA6182_301_2238, Adv Pharmaceutics III
  
• PHA3102_301_2238 Drug Delivery I
  
• PHA4107_301_2238 Drug Delivery III
  
• PHA6517_301_2238 Pharm Concepts Grads
  
• PHA3110_301_2238 Pharmaceutics I
  

---

---

• Google Scholar

• LinkedIn